BPG is committed to discovery and dissemination of knowledge
Editorial
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Orthop. Oct 18, 2025; 16(10): 110077
Published online Oct 18, 2025. doi: 10.5312/wjo.v16.i10.110077
Expanding role of VISA-P in patellofemoral pain assessment-case for caution and context
Conor J Ledingham, Paul O'Grady
Conor J Ledingham, Department of Orthopaedics, Mayo University Hospital, Castlebar F23 F990, Mayo, Ireland
Conor J Ledingham, Department of Orthopaedic Surgery, University of Galway, Galway H91TK33, Ireland
Paul O'Grady, Department of Trauma and Orthopaedic Surgery, Mayo University and Galway University Hospitals, Castelbar F23 H529, Ireland
Author contributions: Ledingham CJ wrote and reviewed the editorial; O'Grady P conceptualised and reviewed the editorial. All authors have read and approved the final manuscript.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Conor J Ledingham, Lecturer, Department of Orthopaedics, Mayo University Hospital, Westport Road, Castlebar F23 F990, Mayo, Ireland. conorledingham22@rcsi.com
Received: May 28, 2025
Revised: June 14, 2025
Accepted: August 22, 2025
Published online: October 18, 2025
Processing time: 140 Days and 23.3 Hours
Abstract

The VISA-P originally developed to assess patellar tendinopathy severity, is increasingly being applied to patellofemoral pain (PFP) assessment. This editorial examines the expanding role of VISA-P within the context of existing patient-reported outcome measures (PROMs) for PFP, such as the Kujala Anterior Knee Pain Scale and the Knee injury and Osteoarthritis Outcome Score for Patellofemoral Pain and Osteoarthritis. While VISA-P offers advantages in brevity, readability, and temporal stability, its original design targeting athletic populations with patellar tendinopathy limits its specificity and comparability when applied broadly to heterogeneous PFP populations. Moreover, VISA-P currently lacks validated diagnostic thresholds to guide clinical decision-making. Although the recent validation of VISA-P in Spanish-speaking populations enhances accessibility, caution is advised in its widespread adoption without clear delineation of its role relative to other PROMs. The editorial argues for careful contextual use of VISA-P, emphasizing the need for tools that balance specificity, efficiency, and universality to capture the complex spectrum of PFP across diverse populations.

Keywords: Patellofemoral pain; Patient-reported outcome measure; VISA-P; Knee; Athletic

Core Tip: The future of patient-reported outcome measures in patellofemoral pain (PFP) must balance specificity, efficiency, and universality. VISA-P may serve a niche-young, athletic, sport-homogenous groups-but broader utility demands either revision or combination with tools that capture the complexity of PFP across diverse demographics.